122 related articles for article (PubMed ID: 21449011)
1. Copper deficiency in Wilson's disease: peripheral neuropathy and myelodysplastic syndrome complicating zinc treatment.
Cortese A; Zangaglia R; Lozza A; Piccolo G; Pacchetti C
Mov Disord; 2011 Jun; 26(7):1361-2. PubMed ID: 21449011
[No Abstract] [Full Text] [Related]
2. Copper deficiency in Wilson's disease: an avoidable complication of treatment.
da Silva-Júnior FP; Lucato LT; Machado AA; Barbosa ER
Mov Disord; 2011 Nov; 26(13):2448-9; author reply 2449-50. PubMed ID: 21956703
[No Abstract] [Full Text] [Related]
3. Axonal sensory motor neuropathy in copper-deficient Wilson's disease.
Foubert-Samier A; Kazadi A; Rouanet M; Vital A; Lagueny A; Tison F; Meissner W
Muscle Nerve; 2009 Aug; 40(2):294-6. PubMed ID: 19609919
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic copper deficiency in three Wilson's disease patients treated with zinc sulphate.
Dzieżyc K; Litwin T; Sobańska A; Członkowska A
Neurol Neurochir Pol; 2014; 48(3):214-8. PubMed ID: 24981187
[TBL] [Abstract][Full Text] [Related]
5. Recovery after copper-deficiency myeloneuropathy in Wilson's disease.
Teodoro T; Neutel D; Lobo P; Geraldo AF; Conceição I; Rosa MM; Albuquerque L; Ferreira JJ
J Neurol; 2013 Jul; 260(7):1917-8. PubMed ID: 23712800
[No Abstract] [Full Text] [Related]
6. [Effectiveness of zinc sulfate in the treatment of Wilson's disease].
Jonderko G; Pluta H; Wieczorek U
Pol Tyg Lek; 1988 Apr; 43(14):459-60. PubMed ID: 3412983
[No Abstract] [Full Text] [Related]
7. Zinc treatment prevents lipid peroxidation and increases glutathione availability in Wilson's disease.
Farinati F; Cardin R; D'inca R; Naccarato R; Sturniolo GC
J Lab Clin Med; 2003 Jun; 141(6):372-7. PubMed ID: 12819634
[TBL] [Abstract][Full Text] [Related]
8. [Effect of oral ZnSO4 on urine copper and blood trace elements in 60 patients with Wilson's disease].
Yang RM
Zhonghua Yi Xue Za Zhi; 1986 Apr; 66(4):211-3, 254. PubMed ID: 3094875
[No Abstract] [Full Text] [Related]
9. Zinc therapy increases duodenal concentrations of metallothionein and iron in Wilson's disease patients.
Sturniolo GC; Mestriner C; Irato P; Albergoni V; Longo G; D'Incà R
Am J Gastroenterol; 1999 Feb; 94(2):334-8. PubMed ID: 10022625
[TBL] [Abstract][Full Text] [Related]
10. Reply to T.U. Hoogenraad's paper published last April. Zinc therapy in Wilson's disease.
Marcellini M; Sartorelli MR; Nobili V
Brain Dev; 2007 Jan; 29(1):55. PubMed ID: 16904856
[No Abstract] [Full Text] [Related]
11. Oral zinc sulphate treatment in Wilson's disease.
Pasqualicchio M; Marrella M; Moretti U; Velo GP; Deganello A; Tomelleri G; Milanino R
Acta Physiol Hung; 1990; 75 Suppl():233-4. PubMed ID: 2371874
[No Abstract] [Full Text] [Related]
12. [Control of the therapeutic prevention of copper uptake in the liver in Wilson's disease following oral administration of 64Cu].
Günther K; Siegemund R; Lössner J; Kühn HJ
Radiobiol Radiother (Berl); 1988; 29(2):226-9. PubMed ID: 3399664
[No Abstract] [Full Text] [Related]
13. [The onset of psychiatric disorders and Wilson's disease].
Benhamla T; Tirouche YD; Abaoub-Germain A; Theodore F
Encephale; 2007 Dec; 33(6):924-32. PubMed ID: 18789784
[TBL] [Abstract][Full Text] [Related]
14. Low-dose zinc therapy for maintenance treatment of Wilson's disease.
Mayet IY
Clin Pharm; 1990 Dec; 9(12):951-3. PubMed ID: 2292179
[No Abstract] [Full Text] [Related]
15. Treatment of Wilson's disease with zinc: X. Intestinal metallothionein induction.
Yuzbasiyan-Gurkan V; Grider A; Nostrant T; Cousins RJ; Brewer GJ
J Lab Clin Med; 1992 Sep; 120(3):380-6. PubMed ID: 1517684
[TBL] [Abstract][Full Text] [Related]
16. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper.
Brewer GJ; Hill GM; Dick RD; Nostrant TT; Sams JS; Wells JJ; Prasad AS
J Lab Clin Med; 1987 May; 109(5):526-31. PubMed ID: 3572199
[TBL] [Abstract][Full Text] [Related]
17. Hemolytic episode in a patient with Wilson's disease treated with zinc.
Shimon I; Moses B; Sela BA; Dolev E
Isr J Med Sci; 1993 Oct; 29(10):646-7. PubMed ID: 8244665
[No Abstract] [Full Text] [Related]
18. Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Sinha S; Taly AB
J Neurol Sci; 2008 Jan; 264(1-2):129-32. PubMed ID: 17765927
[TBL] [Abstract][Full Text] [Related]
19. Paradigm shift in treatment of Wilson's disease: zinc therapy now treatment of choice.
Hoogenraad TU
Brain Dev; 2006 Apr; 28(3):141-6. PubMed ID: 16466879
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Wilson's disease.
Brewer GJ; Yuzbasiyan-Gurkan V; Young AB
Semin Neurol; 1987 Jun; 7(2):209-20. PubMed ID: 3332455
[No Abstract] [Full Text] [Related]
[Next] [New Search]
